CGON
Price:
$72.335
Market Cap:
$6.38B
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent;...[Read more]
Industry
Biotechnology
IPO Date
2024-01-25
Stock Exchange
NASDAQ
Ticker
CGON
According to CG Oncology Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 31.30. This represents a change of 24.11% compared to the average of 25.22 of the last 4 quarters.
The mean historical Current Ratio of CG Oncology Inc. over the last ten years is 18.57. The current 31.30 Current Ratio has changed 16.75% with respect to the historical average. Over the past ten years (40 quarters), CGON's Current Ratio was at its highest in in the March 2024 quarter at 57.95. The Current Ratio was at its lowest in in the March 2023 quarter at 0.
Average
18.57
Median
13.62
Minimum
9.54
Maximum
35.30
Discovering the peaks and valleys of CG Oncology Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 159.17%
Maximum Annual Current Ratio = 35.30
Minimum Annual Increase = -30.22%
Minimum Annual Current Ratio = 9.54
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 24.63 | -30.22% |
| 2024 | 35.30 | 159.17% |
| 2023 | 13.62 | 42.74% |
| 2022 | 9.54 | -2.40% |
The current Current Ratio of CG Oncology Inc. (CGON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
24.51
5-year avg
18.57
10-year avg
18.57
CG Oncology Inc.’s Current Ratio is greater than Celcuity Inc. (12.31), greater than Ascentage Pharma Group International (1.79), greater than Centessa Pharmaceuticals plc (9.53), less than Apogee Therapeutics, Inc. (32.59), greater than Xenon Pharmaceuticals Inc. (27.79), greater than Travere Therapeutics, Inc. (4.05), greater than Ultragenyx Pharmaceutical Inc. (1.73), greater than Legend Biotech Corporation (2.13), greater than Disc Medicine, Inc. (24.14), greater than Tarsus Pharmaceuticals, Inc. (3.74),
| Company | Current Ratio | Market cap |
|---|---|---|
| 12.31 | $4.57B | |
| 1.79 | $1.57B | |
| 9.53 | $6.27B | |
| 32.59 | $8.30B | |
| 27.79 | $6.23B | |
| 4.05 | $5.82B | |
| 1.73 | $2.46B | |
| 2.13 | $3.56B | |
| 24.14 | $2.98B | |
| 3.74 | $2.61B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CG Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is CG Oncology Inc.'s Current Ratio?
How is the Current Ratio calculated for CG Oncology Inc. (CGON)?
What is the highest Current Ratio for CG Oncology Inc. (CGON)?
What is the 3-year average Current Ratio for CG Oncology Inc. (CGON)?
What is the 5-year average Current Ratio for CG Oncology Inc. (CGON)?
How does the current Current Ratio for CG Oncology Inc. (CGON) compare to its historical average?